文献速递细菌感染、耐药与抗菌药物

金黄色葡萄球菌菌血症管理的全球差异:缺乏国际标准治疗规范

Global Differences in the Management of Staphylococcus aureus Bacteremia: No International Standard of Care.
PubMed 文献 · Clin Infect Dis · 2023-01-01

2022年为期20天的全球调查纳入71个国家2031名医生,评估金黄色葡萄球菌菌血症(SAB)的治疗实践。结果显示各洲在MSSA和MRSA菌血症首选治疗、假体材料感染辅助利福平使用、口服抗生素使用及18F-FDG PET/CT应用上存在显著差异(P<.01),持续性SAB定义从2天到7天不等。作者结论为全球SAB实践差异大,反映高质量数据缺乏且无国际标准治疗规范。

要点

  • 各洲在MSSA和MRSA菌血症首选治疗上差异显著(P<.01)。
  • 18F-FDG PET/CT使用率欧洲94%最高,非洲13%最低,北美51%(P<.01)。
  • 持续性SAB定义从欧洲31%受访者用2天到亚洲38%用7天不等(P<.01)。

核心结论

  • 全球SAB管理实践存在巨大差异,反映高质量数据缺乏且缺乏国际标准治疗规范。

研究设计与样本

  • 2022年为期20天的全球医生调查,通过邮件列表、电子邮件和社交媒体分发问卷。
  • 共纳入来自6大洲71个国家的2031名医生。

主要发现

  • 各洲在MSSA和MRSA菌血症首选治疗、假体材料感染辅助利福平使用及口服抗生素使用上差异显著(P<.01)。
  • 18F-FDG PET/CT使用率欧洲94%最高,非洲13%最低,北美51%(P<.01)。
  • 多数受访者将持续性SAB定义为血培养阳性3-4天,但欧洲31%受访者用2天,亚洲38%用7天(P<.01)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite being the leading cause of mortality from bloodstream infections worldwide, little is known about regional variation in treatment practices for Staphylococcus aureus bacteremia (SAB). The aim of this study was to identify global variation in management, diagnostics, and definitions of SAB. METHODS: During a 20-day period in 2022, physicians throughout the world were surveyed on SAB treatment practices. The survey was distributed through listservs, e-mails, and social media. RESULTS: In total, 2031 physicians from 71 different countries on 6 continents (North America [701, 35%], Europe [573, 28%], Asia [409, 20%], Oceania [182, 9%], South America [124, 6%], and Africa [42, 2%]) completed the survey. Management-based responses differed significantly by continent for preferred treatment of methicillin-susceptible S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA) bacteremia, use of adjunctive rifampin for prosthetic material infection, and use of oral antibiotics (P < .01 for all comparisons). The 18F-FDG PET/CT scans were most commonly used in Europe (94%) and least frequently used in Africa (13%) and North America (51%; P < .01). Although most respondents defined persistent SAB as 3-4 days of positive blood cultures, responses ranged from 2 days in 31% of European respondents to 7 days in 38% of Asian respondents (P < .01). CONCLUSIONS: Large practice variations for SAB exist throughout the world, reflecting the paucity of high-quality data and the absence of an international standard of care for the management of SAB.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Westgeest AC, Buis DTP, Sigaloff KCE, et al. Global Differences in the Management of Staphylococcus aureus Bacteremia: No International Standard of Care. Clin Infect Dis. 2023. PMID: 37310693. doi:10.1093/cid/ciad363

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。